http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110201214-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-104
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10
filingDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_927ee0937391cba5e526184a9e98190d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c3cced55b0aa3e7a6ba0411e181be01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608714274be507f90750ff4e0dce1f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9981442059d5d4f8a6a5e32ff9438b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fca9bcfc3ae67ec528be61fc91817e81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d8312c64a75a70d98a36420235370c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51cbc3ec0b28378bfc5338ede0fe9d92
publicationDate 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110201214-A
titleOfInvention Use of a negatively charged injectable gelatin microsphere-based gel as a hemostatic material
abstract The invention discloses the use of a negatively charged injectable gelatin microsphere-based gel as a hemostatic material. The gelatin microsphere-based gel hemostatic material is made into a gelatin microsphere-based gel through the hydration of gelatin microspheres and water, which gives it injectability and can be injected through a common syringe; At the same time, based on the characteristics of gelatin itself, which absorbs water and can be absorbed and degraded, the injected hemostatic gel absorbs blood and swells and compresses the wound blood vessels, reducing blood flow to achieve hemostasis and hemostasis. The gel does not have to be taken out, thereby reducing the secondary injury to the patient.
priorityDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009123903-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11953960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID306761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115

Total number of triples: 46.